Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Boston Medical Group vs NativeMed

Boston Medical Group
Graded #113

Higher grade

vs+3.4000000000000057
NativeMed
Graded #190

Lower grade

The verdict

Boston Medical Group takes it — 69.9/100 to 66.5/100.

Boston Medical Group grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established medical group offering a 3-month semaglutide weight loss program.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBoston Medical Group +12
86
74
Dose & formulationNativeMed +12
52
64
Clinical oversightBoston Medical Group +15
89
74
Labs & monitoringEven
53
53
FulfillmentNativeMed +2
65
67
Contract termsEven
55
55
Boston Medical Group · left barNativeMed · right bar

The numbers

MetricBoston Medical GroupNativeMed
WeighScore69.9/10066.5/100
GradeCC
Scorecard rank#113#190
Semaglutide$66/mo (starting dose, compounded)$149/mo (promotional rate, compounded)
TirzepatideNot disclosed$183/mo (promotional rate, compounded)
Coverage7 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Boston Medical Group

Graded #113 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
NativeMed

Graded #190 · C

Strengths

  • LegitScript Certified (verifiable in the footer)
  • Promotional pricing shown publicly: $149/mo semaglutide, $183/mo tirzepatide
  • Online questionnaire intake, with a live visit added when state law requires it

Where it loses points

  • Pharmacy partners aren't named — described only as 'USA-based' or 'accredited' pharmacies
  • States served aren't listed publicly
  • Prices are promotional — confirm whether they hold past month one or rise to the $299/$399 regular rate

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard